Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Cash from Operations (2021 - 2025)

Historic Cash from Operations for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to -$2.3 million.

  • HeartSciences' Cash from Operations fell 690.23% to -$2.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was -$7.5 million, marking a year-over-year increase of 484.32%. This contributed to the annual value of -$7.4 million for FY2025, which is 2212.14% down from last year.
  • As of Q4 2025, HeartSciences' Cash from Operations stood at -$2.3 million, which was down 690.23% from -$2.0 million recorded in Q3 2025.
  • In the past 5 years, HeartSciences' Cash from Operations registered a high of -$717491.0 during Q3 2021, and its lowest value of -$2.3 million during Q4 2025.
  • Over the past 5 years, HeartSciences' median Cash from Operations value was -$1.6 million (recorded in 2024), while the average stood at -$1.5 million.
  • As far as peak fluctuations go, HeartSciences' Cash from Operations crashed by 15250.6% in 2022, and later soared by 2288.88% in 2025.
  • Quarter analysis of 5 years shows HeartSciences' Cash from Operations stood at -$768053.0 in 2021, then plummeted by 40.63% to -$1.1 million in 2022, then grew by 8.51% to -$988187.0 in 2023, then crashed by 120.97% to -$2.2 million in 2024, then dropped by 6.9% to -$2.3 million in 2025.
  • Its last three reported values are -$2.3 million in Q4 2025, -$2.0 million for Q3 2025, and -$1.6 million during Q2 2025.